← Back to All Filings

Institutional Holder Opaleye Buys More SANUWAVE (SNWV) Stock

Low SignificanceOctober 9, 2025 at 7:35:22 PM EDT

SANUWAVE Health, Inc.

$SNWV4CIK: 0001417663

Subscribe to track SNWV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Institutional Holder Opaleye Buys More SANUWAVE (SNWV) Stock

Company: SANUWAVE Health, Inc. (SNWV) Form: 4 | Filed: 2025-10-09 Significance: Low

Insider: Opaleye Management Inc. Title: null | Relationship: 10% Owner

Transaction: • Type: Purchase • Shares: 1,267 • Price: $30.28 • Value: $38,360.16 • Owned After: 966,267 (in this fund)

Key Insight: A 10% owner, Opaleye Management, made a small open-market purchase, slightly increasing its position. The low value suggests a routine transaction rather than a high-conviction move.

Market Context: This filing reports a routine accumulation by an existing institutional investor. The price is a weighted average, indicating multiple small purchases.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: SANUWAVE Health, Inc. (SNWV)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Opaleye Management Inc., a 10% beneficial owner, executed a small open-market purchase of SANUWAVE Health, Inc. stock, valued at approximately $38,360. Given the small size of the transaction relative to their total holdings, the signal is considered weak.
  • Market Impact: The transaction is unlikely to have a significant market impact due to its low dollar value. It represents a minor, routine accumulation by an existing institutional holder.

Company Information

FieldValue
CompanySANUWAVE Health, Inc.
Ticker SymbolSNWV
CIK0001417663
IndustrySurgical & Medical Instruments & Apparatus [3841]

Insider Information

FieldValue
NameOpaleye Management Inc.
CIK0001595855
Title/Positionnull
Relationship10% Owner

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-06
Transaction CodeP (Open Market Purchase)
Security TypeCommon Stock, par value $0.001 per share
Shares Involved1,267
Price Per Share$30.277 (Weighted Average)
Total Value$38,360.16
Shares Owned After966,267 (Indirectly by Opaleye, L.P.)
Ownership TypeIndirect

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: While insider purchases are generally bullish, the total value of this transaction is too small to be considered a strong signal of insider confidence. It is more likely a routine portfolio adjustment or small-scale accumulation by the investment fund.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The trade size is insignificant and unlikely to influence trading volume.
  • Sentiment Indicator: Neutral. The market is likely to view this as a non-event due to the low transaction value.

Investment Insights

Positive Market Indicators

  • The transaction is a purchase ('P' code), which is a fundamentally positive action, indicating the insider is adding to their position rather than reducing it.
  • The filer is a significant institutional owner (10%+), suggesting continued interest in the company.

Risk Factors

  • The very small size of the purchase diminishes its signaling power significantly.
  • As an investment manager, Opaleye's trading may be driven by fund-level portfolio management strategies rather than a fundamental change in outlook on SANUWAVE Health itself.

Key Takeaways

  1. Minor Accumulation: Opaleye Management Inc. continues to hold a significant stake and made a minor addition.
  2. Low Conviction Signal: The purchase of only ~$38k worth of stock does not represent a high-conviction bet on the company's future performance.
  3. Indirect Ownership: The shares are held indirectly through funds managed by Opaleye, which is a typical structure for institutional investors.

Contextual Analysis

Timing Significance

  • The transaction occurred on October 6, 2025, and was reported timely on October 9. There is no apparent link to immediate major corporate news that would give the timing special significance.

Transaction Context

  • Footnote F3 clarifies that the reported price is a weighted average from multiple transactions with prices ranging from $29.75 to $30.50. This confirms the nature of the transaction as a series of small buys.
  • Footnote F1 and F2 specify the indirect ownership structure: the shares are owned by Opaleye, L.P. (a fund) and a separately managed account, for which Opaleye Management Inc. acts as the investment manager.

Company Context

  • SANUWAVE Health, Inc. operates in the medical instruments sector. Investors should consider this purchase in the context of the company's recent performance, product pipeline, and overall industry trends.

Risk Assessment

Risk Level: Low

Risk Factors

  • Interpretation Risk: Misinterpreting this small, routine purchase as a strong bullish signal could be a mistake.
  • Fund Strategy: The purchase could be part of a broader, diversified fund strategy and not specific to SANUWAVE's individual prospects.

Market Considerations

  • Small-Cap Volatility: As a smaller company, its stock may be subject to volatility unrelated to this specific insider transaction.
  • Institutional Holdings: It's important to monitor the overall trend of institutional ownership, not just a single small trade.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-09 | Data source: SEC EDGAR

Topics:#SECFiling#Form4#InsiderTrading#SNWV#SNWVStock#InsiderBuy#OpaleyeManagement#StockMarket#Investing#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.